Ventilation-Associated Particulate Matter Is a Potential Reservoir of Multidrug-Resistant Organisms in Health

Evgenia Chezganova1, Olga Efimova2, Vera Sakharova3

  • 1Department of Epidemiology, Kemerovo State Medical University, 650056 Kemerovo, Russia.

Insights

Ventilation system dust (Vent-PM) in healthcare facilities can harbor multidrug-resistant organisms (MDRO) and viruses, posing a risk for healthcare-associated infections (HCAIs). This previously underestimated reservoir highlights the need for improved environmental monitoring and control strategies.

Area of Science:

  • Environmental microbiology
  • Infection control
  • Public health

Background:

  • Healthcare-associated infections (HCAIs) are often caused by multidrug-resistant organisms (MDRO) colonizing patients and staff.
  • The role of ventilation systems as potential reservoirs for microbial pathogens in healthcare settings remains underexplored.

Purpose of the Study:

  • To investigate if particulate matter from healthcare ventilation systems (Vent-PM) harbors MDRO and other microbes.
  • To assess Vent-PM as a potential reservoir for HCAIs.

Main Methods:

  • Physicochemical properties and biodiversity analysis of dust samples from ventilation grilles and air ducts.
  • Identification of microbial contaminants, including viruses and multidrug-resistant bacteria.
  • Correlation of microbial contamination with air flow and facility type.

Main Results:

  • Ultrafine particulate matter (PM) capable of reaching alveoli was present in all samples.
  • >70% of Vent-PM samples were contaminated with viruses (>15%) or multidrug-resistant, biofilm-producing bacteria (60% and 48%).
  • Bacterial contamination increased with air flow, and microbial composition varied by care unit type and facility location.

Conclusions:

  • Vent-PM serves as a significant reservoir for HCAI-causing pathogens.
  • Findings indicate evolving antibiotic resistance within hospital environments.
  • Highlights the need for considering ventilation systems in infection control strategies.

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.3K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
437
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
531
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
673
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.2K